We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 187.50
Bid: 180.00
Ask: 195.00
Change: 0.00 (0.00%)
Spread: 15.00 (8.333%)
Open: 187.50
High: 187.50
Low: 187.50
Prev. Close: 187.50
SNX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Business Update: COVID-19

23 Mar 2020 14:28

RNS Number : 2442H
Synectics PLC
23 March 2020
 

 

 

For immediate release

 

23 March 2020

 

 

Synectics plc

("Synectics" or "the Company")

 

Business Update: COVID-19

Synectics plc (AIM: SNX) provides the following update on the measures the Company is taking in response to the developing COVID-19 situation.

The Board is closely monitoring the effect Coronavirus (COVID-19) is having on Synectics' customers, business and employees, and are making necessary decisions daily to meet the rapidly changing situation.

The business has a solid cash position, and has measures already in place to ensure it remains financially sound during this period of uncertainty, and beyond.

Business Operations

The Company's business is to provide security and safety systems: Our employees and customers are acutely aware of the vital role they play in protecting communities around the world, and are making every effort to ensure our customers can rely on us at this difficult time.

Although we anticipate significant, unavoidable disruption, we are using best endeavours to continue essential service and support to our customers.

The priorities for the Board are to:

§ protect the health and well-being of our employees and customers;

§ provide ongoing support to our customers, especially where we are providing essential security and safety; and

§ manage our business for the long term by prudent actions to preserve cash and maintain capability.

Changes to Working Practices

As an International business, we are closely following all National government regulations and guidance wherever we operate - regarding travel, working practices, 'stay home' notifications, healthcare, and well-being.

We have taken significant steps to protect colleagues and customers, while actioning robust continuity plans to minimise disruption - which we are constantly reviewing and updating.

We suspended all business travel at the start of last week, re-arranged working patterns at all Synectics sites, and implemented measures such as increasing remote support, and ensuring our teams can work from home. 

Most employees are now working from home, or on rotation: with an expected significant and extended increase in homeworking, which many of our colleagues have no experience of, we have instigated a specific programme to keep colleagues connected to the business and each other, to facilitate continued teamwork and avoid feelings of isolation.

 

Financial Position

The business has a solid cash position. Currently available cash balance was £4.1M as of 20 March 2020, with confirmed facilities of £5M in place if required.

Measures have already been put in place to curb discretionary spending and to preserve cash. All recruitment and non-critical capital expenditures are on hold. Stocking plans are being adjusted daily based on customers' committed requirements.

These actions should ensure that the business remains financially sound during this period of uncertainty and beyond.

We also note and welcome the UK Government's "Coronavirus Job Retention Scheme" and we await further details on how this will operate.

 

AGM

The Company still expects to hold its Annual General Meeting ("AGM") on 23 April 2020, but the venue for this has been changed to its offices in Sheffield and proceedings will be broadcast online.

The Board would encourage all shareholders who wish to do so to vote online at www.signalshares.com rather than attend the AGM in person.

In order to reduce the risk of infection, the meeting will end immediately following the business of the AGM.

Instructions on proxy voting are attached to the Notice of Meeting enclosed with the 2019 Annual Report which has already been sent out to shareholders and which can be found on the Company's website.

 

Dividend

The Board has recommended the payment of a final dividend for the year ended 30 November 2019 of 3.5p per share, subject to approval by shareholders at the Company's AGM on 23 April 2020.

Given the current situation and the desire to preserve cash, the Board believes it is appropriate and prudent to cancel the final dividend payment for the year ended 30 November 2019 and therefore intends to withdraw the relevant resolution at the AGM.

The Board will review the situation later in the year.

 

Outlook

The priorities for the Board are as set out above. We are a global business with a solid balance sheet, and we have taken immediate measures to contain costs and protect our financial position.

Modest trading in Q1 was expected to be followed by a strong Q2 performance. However given the continued uncertainty, the Board wishes to withdraw financial guidance on expected trading performance for the financial year ending 30 November 2020.

The Board will continue to monitor the situation closely and provide a further update at the time of the AGM on 23 April 2020.

 

Paul Webb

Chief Executive

 

23 March 2020

For further information, please contact:

Synectics plc

Tel: +44 (0) 114 280 2828

Paul Webb, Chief Executive

 

David Bedford, Finance Director

 

email: info@synecticsplc.com

www.synecticsplc.com

 

 

Shore Capital

Tel: +44 (0) 20 7408 4050

Tom Griffiths / Henry Willcocks

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDEALDDAALEEFA
Date   Source Headline
17th Apr 20247:00 amRNSContract win with a major UK utility provider
9th Apr 20247:00 amRNSBoard Appointment and Grant of Options
3rd Apr 20247:00 amRNSDirector/PDMR Dealings
26th Mar 20247:00 amRNSDirectors / PDMRs' Interests in Shares
26th Mar 20247:00 amRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSPosting of Annual Report & Accounts, Notice of AGM
27th Feb 20247:00 amRNSFinal Results
7th Feb 20247:00 amRNSNotice of Results and Investor Presentation
30th Jan 20247:00 amRNSContract Awards
19th Dec 20233:00 pmRNSHolding(s) in Company
11th Dec 20237:00 amRNSTrading Update
29th Nov 20237:00 amRNSContract Win
15th Nov 20237:00 amRNSInvestor Site Visit
23rd Oct 20237:00 amRNSDirectorate Changes
16th Oct 20237:00 amRNSLatest Release of Synectics’ Synergy Software
11th Oct 20237:00 amRNSDirector/PDMR Dealings
28th Sep 20237:00 amRNSAdditional Contract with West Midlands Police
11th Jul 20237:00 amRNSHalf-year Report
4th Jul 20237:00 amRNSContract Award
3rd Jul 20237:00 amRNSInvestor Presentation re interim results
19th Jun 20237:00 amRNSTrading Update and Notification of Results
11th May 20237:00 amRNSDirector dealings
2nd May 20237:00 amRNSNew Gaming Project in Asia
27th Apr 202311:51 amRNSResult of AGM
27th Apr 20237:00 amRNSAGM Statement
13th Apr 20237:00 amRNSContract Award
4th Apr 20238:09 amRNSDirector/PDMR Shareholding
23rd Mar 20237:00 amRNSPosting of Accounts and Notice of AGM
14th Mar 20237:00 amRNSPDMRs' Interests in Shares
22nd Feb 20237:00 amRNSFinal Results
17th Feb 20237:00 amRNSDirectorate Change
13th Feb 20237:00 amRNSNotice of Results
13th Dec 20227:00 amRNSTrading Update
1st Dec 20227:00 amRNSCompletion of sale of non-core Business
11th Nov 20227:00 amRNSSale of non-core Business
7th Nov 20227:00 amRNSDirectorate Change
24th Oct 20227:00 amRNSBoard Change and Update on Chairman Recruitment
4th Oct 20227:00 amRNSDirector/PDMR Shareholding
2nd Aug 20227:00 amRNSDirector’s and PDMRs' Interests in Share Schemes
12th Jul 20227:00 amRNSHalf-year Report
5th Jul 202212:00 pmRNSInvestor Presentation
5th Jul 20227:00 amRNSDirectorate Change
22nd Jun 20227:00 amRNSProposed Board Change
14th Jun 20227:00 amRNSTrading Update
1st Jun 20227:00 amRNSDirectorate Change
12th May 20228:12 amRNSDirector/PDMR Shareholding
11th May 20227:00 amRNSAmendment to Performance Share Plan
10th May 20227:00 amRNSDirector/PDMR Shareholding
20th Apr 202212:05 pmRNSResult of AGM
20th Apr 20227:00 amRNSAGM Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.